Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SPECTOR, R. H.
Right arrow Articles by SCHWARTZMAN, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SPECTOR, R. H.
Right arrow Articles by SCHWARTZMAN, R. J.
NEUROLOGY 1976;26:1031
© 1976 American Academy of Neurology

Phenytoin-induced ophthalmoplegia

ROBERT H. SPECTOR, M.D., ROBERT A. DAVIDOFF, M.D. and ROBERT J. SCHWARTZMAN, M.D.

From the Department of Neurology, University of Miami School of Medicine, and the Neurology Service, Veterans Administration Hospital, Miami, Florida.

Total external ophthalmoplegia was observed in five patients consequent to the oral or intravenous administration of phenytoin. Coincident with the ophthalmoplegia, the state of consciousness varied from drowsiness to coma and the blood levels of phenytoin ranged from 36 to 55 µg per milliliter. Initially, the eyes were fixed in midposition, and oculocephalic and oculovestibular stimulation failed to evoke either horizontal or vertical eye movements. The return of vestibulo-ocular responsiveness lagged behind the return of consciousness and other reflex activity. The mechanism underlying this ophthalmoplegia may be related to the ability of phenytoin to potentiate inhibitory synapses in the vestibulo-oculomotor pathway which utilize gamma aminobutyric acid, and to increase the discharge rate of Purkinje cells which exert an inhibitory influence on the same structures.

Dr. Davidoff s address is Neurology Service (180), Veterans Administration Hospital, 1201 N. W. 16th Street, Miami, FL 33125.

Presented in part at the twenty-seventh annual meeting of the American Academy of Neurology, Bal Harbour, Florida, May 1975.

Received for publication November 24, 1975.




This article has been cited by other articles:


Home page
Arch NeurolHome page
W. J. Mullally
Carbamazepine-Induced Ophthalmoplegia
Arch Neurol, January 1, 1982; 39(1): 64 - 64.
[Abstract] [PDF]


Home page
Arch NeurolHome page
R. F. Saul and J. B. Selhorst
Downbeat Nystagmus With Magnesium Depletion
Arch Neurol, October 1, 1981; 38(10): 650 - 652.
[Abstract] [PDF]


Home page
Arch NeurolHome page
F. F. Cook, R. G. Davis, and L. S. Russo Jr
Internuclear Ophthalmoplegia Caused by Phenothiazine Intoxication
Arch Neurol, July 1, 1981; 38(7): 465 - 466.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1976 by AAN Enterprises, Inc.